← Back to Dashboard
Therapeutic & Diagnostic Innovation

Diabetes Mellitus

Origin Data Source OpenAlex
Analysis Computed Oct 6, 2026
AI Synthesis & Market Narrative
Pharmaceutical innovation continues with new dual-biased GLP-1/GIP agonists demonstrating significant weight loss in Phase III trials. Concurrently, AI-driven ensemble learning methods are advancing diabetes disease classification, and the veterinary market presents a notable segment for diabetes care.
Correlated Linguistic Patterns
["type 2 diabetes" "dual-biased GLP-1\/GIP Agonist" "19.3% Weight Loss" "ensemble learning methods in diabetes disease classification" "pets in the US have diabetes"]
Driving Media Context
Nature.com • Oct 3, 2026

History of miscarriage and type 2 diabetes

Scientific Reports - History of miscarriage and type 2 diabetes
PRNewswire • Oct 2, 2026

19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD

MILAN, Oct. 2, 2026 /PRNewswire/ -- From September 28 to October 2, 2026, the Annual Meeting of the European Association for the Study of Diabetes (EASD) is ...
Nature.com • Sep 29, 2026

Evaluating the performance of ensemble learning methods in diabetes disease classification

Scientific Reports - Evaluating the performance of ensemble learning methods in diabetes disease classification
Plos.org • Sep 28, 2026

The inverted pyramid of care in modern-day obstetrics

In this Policy Forum, Laura Magee and colleagues provide updated guidance for ‘inverted’ antenatal care, including optimal screening timepoints and the most ...
Lifesciencesworld.com • Sep 27, 2026

How many pets in the US have diabetes?

How Many Pets in the US Have Diabetes: Understanding the Scope and Impact The exact number of pets in the US with diabetes is difficult to pinpoint precisely...
FDA.gov • Sep 24, 2026

FDA Approves Once-Weekly Insulin for Type 2 Diabetes Mellitus

The U.S. Food and Drug Administration has approved Onswik (insulin efsitora alfa-gobe) injection, a long-acting insulin analog, as an adjunct to diet and exe...
PRNewswire • Sep 22, 2026

NUH ENDOCRINOLOGY TEAM SHOWCASES END-TO-END CARE MODEL THAT PROTECTS HOSPITALISED PATIENTS WITH DIABETES MELLITUS (DM) ACROSS THEIR CARE JOURNEY

NUH's Inpatient DM management team highlights how safe prescribing is strengthened through proactive monitoring, rapid intervention and coordinated care tran...
The BMJ • Sep 22, 2026

Nomogram for predicting implant exposure risk following enucleation or evisceration with vicryl-meshed hydroxyapatite implants

Aims To develop and validate a nomogram predicting the risk of implant exposure in patients receiving vicryl-meshed hydroxyapatite (HA) orbital implants foll...
Lifesciencesworld.com • Sep 21, 2026

Can elephants have diabetes?

Can Elephants Have Diabetes?: Unveiling the Gentle Giant’s Metabolic Secret Yes, elephants can indeed develop diabetes. This condition, surprisingly, is beco...
Nature.com • Sep 12, 2026

Evaluation of renal function tests and serum electrolytes in diabetic and non-diabetic individuals: a comparative cross-sectional study

Scientific Reports - Evaluation of renal function tests and serum electrolytes in diabetic and non-diabetic individuals: a comparative cross-sectional study